AI-generated summary
The authors report a prospective study at three Japanese sites of intense pulsed light combined with meibomian gland expression in 31 patients with refractory obstructive meibomian gland dysfunction. Symptom scores and several tear film measures improved after treatment, while meiboscore and Schirmer test values did not change, and the authors describe the treatment as a promising option.
- Participants
- 31
- Who or what was studied
- Patients with refractory obstructive meibomian gland dysfunction enrolled at 3 sites in Japan (62 eyes of 31 patients; mean age 47.6 years)
- Limits stated in the abstract
- The abstract does not describe a control group, and the single-arm prospective design with 31 patients limits the strength of the conclusions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.